BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2803943)

  • 1. A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334).
    Freeman SN; Mainwaring WI; Furr BJ
    Br J Cancer; 1989 Nov; 60(5):664-8. PubMed ID: 2803943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of Casodex (bicalutamide): preclinical studies.
    Furr BJ
    Eur Urol; 1996; 29 Suppl 2():83-95. PubMed ID: 8717469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat.
    Chandolia RK; Weinbauer GF; Simoni M; Behre HM; Nieschlag E
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):547-55. PubMed ID: 1759544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ; Tucker H
    Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen.
    Furr BJ; Valcaccia B; Curry B; Woodburn JR; Chesterson G; Tucker H
    J Endocrinol; 1987 Jun; 113(3):R7-9. PubMed ID: 3625091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural and quantitative immunohistochemical changes induced by nonsteroid antiandrogens on pituitary gonadotroph population of prepubertal male rats.
    Cónsole GM; Jurado SB; Rulli SB; Calandra RS; Gómez Dumm CL
    Cells Tissues Organs; 2001; 169(1):64-72. PubMed ID: 11340263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
    Furr BJ
    Horm Res; 1989; 32 Suppl 1():69-76. PubMed ID: 2533159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two non-steroidal antiandrogens on testicular function in prepubertal rats.
    Rulli SB; Gonzalez-Calvar SI; Campo S; Calandra RS
    J Androl; 1995; 16(3):225-32. PubMed ID: 7559155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a peripherally selective antiandrogen (Casodex) as a tool for studying the relationship between testosterone and spermatogenesis in the rat.
    Chandolia RK; Weinbauer GF; Behre HM; Nieschlag E
    J Steroid Biochem Mol Biol; 1991 Mar; 38(3):367-75. PubMed ID: 1848993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro effects of the pure antiandrogens OH-flutamide, Casodex, and nilutamide on androgen-sensitive parameters.
    Simard J; Singh SM; Labrie F
    Urology; 1997 Apr; 49(4):580-6; discussion 586-9. PubMed ID: 9111629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of androgens and antiandrogens on the quantitative immunohistochemistry of gonadotrope cells in prepubertal male rats.
    Cónsole GG; Rulli SB; Riccillo FL; Calandra RS; Gómez Dumm CL
    Neuroendocrinology; 1999 Oct; 70(4):261-7. PubMed ID: 10529621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours.
    Maucher A; von Angerer E
    J Cancer Res Clin Oncol; 1993; 119(11):669-74. PubMed ID: 8349724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective binding of Casodex to the androgen receptor.
    Mukherjee A; Kirkovsky L; Yao XT; Yates RC; Miller DD; Dalton JT
    Xenobiotica; 1996 Feb; 26(2):117-22. PubMed ID: 8867996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.
    Luo S; Martel C; Chen C; Labrie C; Candas B; Singh SM; Labrie F
    Urology; 1997 Dec; 50(6):913-9. PubMed ID: 9426723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antiandrogens casodex and epitestosterone on bone composition in mice.
    Broulik PD; Stárka L
    Bone; 1997 May; 20(5):473-5. PubMed ID: 9145245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective metabolism and pharmacokinetics of Casodex in the male rat.
    McKillop D; Simons PJ; Cockshott ID; Hill SJ; Harding JR; Cooper KJ; Jones DC
    Xenobiotica; 1995 Jun; 25(6):623-33. PubMed ID: 7483662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
    Furr BJ
    Prog Clin Biol Res; 1988; 260():13-26. PubMed ID: 2966405
    [No Abstract]   [Full Text] [Related]  

  • 18. Casodex: preclinical studies and controversies.
    Furr BJ
    Ann N Y Acad Sci; 1995 Jun; 761():79-96. PubMed ID: 7625752
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex.
    Waller AS; Sharrard RM; Berthon P; Maitland NJ
    J Mol Endocrinol; 2000 Jun; 24(3):339-51. PubMed ID: 10828827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and biological activities of pituitary FSH isoforms in prepubertal male rats: effect of antiandrogens.
    Rulli SB; Creus S; Pellizzari E; Cigorraga SB; Calandra RS; Campo S
    Neuroendocrinology; 1996 Jun; 63(6):514-21. PubMed ID: 8793893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.